Ensifentrine

Overview

Ensifentrine is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL4594287).

API suppliers (3)

Suppliers of Ensifentrine backed by a verifiable FDA Type II Drug Master File. Source: FDA quarterly DMF list.

• BREATHGREEN PHARMACEUTICAL CO LTD1 active DMF
• Cipla USA, Inc.USA1 active DMF
• MAHIMA LIFE SCIENCES PRIVATE LTDIndia1 active DMF

Patent & exclusivity (US)

Per the FDA Orange Book (1 approved US product), the latest listed US patent on Ensifentrine expires 25 Jun 2044 and exclusivity 26 Jun 2029. Generic API sourcing typically opens up once these lapse.